This research aims to analyze the safety of antipsoriatic medications utilizing registry data.
Explored existing registry data on antipsoriatic medications.
Assessed safety profiles and adverse effects based on reported data.
Identified key safety concerns associated with various antipsoriatic medications.
Provided evidence supporting the necessity for thorough safety evaluations in existing treatments.
Resumen
Brigitte Stephan; Antipsoriatic medications and their safety: why seeking for registry data exploration, British Journal of Dermatology, , ljag250, https:/